Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Aim 2

Grant

Awarded By

Total Award Amount

  • 90000.00
  • Direct Costs

  • 60606.00
  • Sponsor Award Id

  • N006814101
  • Contributor

  • Michael Seifert   Principal Investigator